Načítá se...
Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?
Gastric cancer is the third leading cause of cancer-related death globally with approximately 723 000 deaths every year. Most patients present with advanced unresectable or metastatic disease, only amenable to palliative systemic treatment and a median survival uncommonly exceeding 12 months. Over t...
Uloženo v:
| Vydáno v: | ESMO Open |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
ESMO Open
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5703389/ https://ncbi.nlm.nih.gov/pubmed/29209523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000206 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|